Delivra Health Brands Inc. (DHBUF)
OTCMKTS
· Delayed Price · Currency is USD
0.1292
+0.0067 (5.47%)
At close: Apr 25, 2025
Delivra Health Brands Income Statement
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2019 |
Revenue | 12.57 | 12.38 | 9.79 | 8.14 | 7.96 | 7.78 | Upgrade
|
Revenue Growth (YoY) | 10.37% | 26.42% | 20.30% | 2.30% | 2.24% | 30.09% | Upgrade
|
Cost of Revenue | 6.31 | 5.98 | 4.97 | 5.54 | 6.04 | 5.48 | Upgrade
|
Gross Profit | 6.26 | 6.4 | 4.82 | 2.6 | 1.92 | 2.31 | Upgrade
|
Selling, General & Admin | 6.34 | 5.77 | 4.7 | 6.15 | 8.31 | 11.88 | Upgrade
|
Research & Development | - | - | - | - | 0.07 | 0.18 | Upgrade
|
Operating Expenses | 7.81 | 7.11 | 6.19 | 8.62 | 11.18 | 16.42 | Upgrade
|
Operating Income | -1.55 | -0.71 | -1.36 | -6.01 | -9.26 | -14.11 | Upgrade
|
Interest Expense | -0.17 | -0.17 | -0.25 | -0.64 | - | -0.32 | Upgrade
|
Interest & Investment Income | - | - | - | - | 0.04 | - | Upgrade
|
Earnings From Equity Investments | - | - | - | - | - | -0.2 | Upgrade
|
Currency Exchange Gain (Loss) | -0.01 | -0.07 | -0.05 | 0.01 | 0 | -0.02 | Upgrade
|
Other Non Operating Income (Expenses) | -0.08 | - | - | - | - | -0.48 | Upgrade
|
EBT Excluding Unusual Items | -1.81 | -0.94 | -1.67 | -6.64 | -9.22 | -15.12 | Upgrade
|
Merger & Restructuring Charges | - | - | - | - | - | -1.61 | Upgrade
|
Impairment of Goodwill | - | - | - | - | - | -41.12 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | -0.02 | 0.49 | -0.6 | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.04 | -0.04 | 0.6 | -0.69 | -0.24 | -0.49 | Upgrade
|
Asset Writedown | - | - | - | -0.4 | -12.11 | - | Upgrade
|
Other Unusual Items | 1.86 | 1.86 | 0.9 | 0.23 | -0.5 | -0.39 | Upgrade
|
Pretax Income | 0.01 | 0.88 | -0.18 | -7.01 | -22.67 | -58.74 | Upgrade
|
Earnings From Continuing Operations | 0.01 | 0.88 | -0.18 | -7.01 | -22.67 | -58.74 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | -5.87 | -22.66 | Upgrade
|
Net Income to Company | 0.01 | 0.88 | -0.18 | -7.01 | -28.54 | -81.39 | Upgrade
|
Minority Interest in Earnings | - | - | - | - | - | 1.54 | Upgrade
|
Net Income | 0.01 | 0.88 | -0.18 | -7.01 | -28.54 | -79.86 | Upgrade
|
Net Income to Common | 0.01 | 0.88 | -0.18 | -7.01 | -28.54 | -79.86 | Upgrade
|
Shares Outstanding (Basic) | 31 | 29 | 25 | 25 | 23 | 22 | Upgrade
|
Shares Outstanding (Diluted) | 31 | 29 | 25 | 25 | 23 | 22 | Upgrade
|
Shares Change (YoY) | 22.21% | 13.08% | - | 11.80% | 5.06% | 19.64% | Upgrade
|
EPS (Basic) | 0.00 | 0.03 | -0.01 | -0.28 | -1.26 | -3.71 | Upgrade
|
EPS (Diluted) | 0.00 | 0.03 | -0.01 | -0.28 | -1.26 | -3.71 | Upgrade
|
Free Cash Flow | 0.41 | 0.76 | -1.09 | -4.45 | -9.68 | -24.65 | Upgrade
|
Free Cash Flow Per Share | 0.01 | 0.03 | -0.04 | -0.18 | -0.43 | -1.15 | Upgrade
|
Gross Margin | 49.81% | 51.70% | 49.26% | 31.99% | 24.12% | 29.64% | Upgrade
|
Operating Margin | -12.31% | -5.74% | -13.92% | -73.87% | -116.39% | -181.30% | Upgrade
|
Profit Margin | 0.07% | 7.08% | -1.88% | -86.12% | -358.70% | -1026.18% | Upgrade
|
Free Cash Flow Margin | 3.24% | 6.11% | -11.11% | -54.69% | -121.67% | -316.78% | Upgrade
|
EBITDA | -0.25 | 0.6 | -0.03 | -3.94 | -7.04 | -11.41 | Upgrade
|
EBITDA Margin | -1.96% | 4.84% | -0.34% | -48.42% | -88.54% | -146.57% | Upgrade
|
D&A For EBITDA | 1.3 | 1.31 | 1.33 | 2.07 | 2.22 | 2.7 | Upgrade
|
EBIT | -1.55 | -0.71 | -1.36 | -6.01 | -9.26 | -14.11 | Upgrade
|
EBIT Margin | -12.31% | -5.74% | -13.92% | -73.87% | -116.39% | -181.30% | Upgrade
|
Revenue as Reported | 12.57 | 12.38 | 9.79 | 8.14 | 7.96 | 7.78 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.